Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New study shows how to eliminate motion sickness on tilting trains

05.08.2011
An international team of researchers led by scientists at Mount Sinai School of Medicine have found that motion sickness on tilting trains can be essentially eliminated by adjusting the timing of when the cars tilt as they enter and leave the curves.

They found that when the cars tilt just at the beginning of the curves instead of while they are making the turns, there was no motion sickness. The findings were published online Monday, July 25 in the Federation of American Societies for Experimental Biology (FASEB) Journal.

When a tilting train enters a curve, sensors on the front wheels of the train signal to the remaining cars when they should begin their tilt. In this reactive mode, since the sensors cannot be activated until the first car is in the curve, there is an inevitable delay in the onset of the tilt. In addition, the cars tilt more slowly. The researchers established that the late, slow rise in the velocity of the tilt during the curves coupled with the centrifugal force produced by the turn, causes motion sickness.

In contrast, when the curves were sensed from the geographic position of the train on the tracks, determined by a global positioning system (GPS), the tilts occurred earlier and were faster, and motion sickness was eliminated. In this predictive mode, lateral thrust was also reduced as the train rounded curves, making it much easier to walk in the aisles.

"This is a major breakthrough and a very practical solution to a problem affecting people's everyday lives," said Dr. Bernard Cohen, lead author of the study and Professor of Neurology at Mount Sinai School of Medicine.

The Schweizerische Bundeshanen (SBB), the train system in Switzerland that requested this study, serviced 347 million passengers in 2010. The SBB wanted to order new trains that would maximize train speed and passenger comfort. Tilting trains are utilized world-wide to compensate for the centripetal acceleration during turns, allowing the trains to run faster. However, the tilting has also led to motion sickness.

"After seeing the results of the study, the SBB invested 3.2 billion Swiss francs for trains utilizing the results of the new technology that came from these experiments," said Dr. Cohen. "Hopefully we'll see this trend extend to other European and American markets as well."

During the study, the researchers placed angular velocity and lateral acceleration sensors on the front car in a seven-car train as well as on the heads of passengers. Over the course of about two months they used three control modes to evaluate the levels of motion sickness in 200 passengers: an untilted mode, a reactive mode based on the information from the front wheel set, and a predictive mode based on the information from the GPS. Passengers had no motion sickness in the untilted mode, showing that the lateral acceleration itself was not responsible for producing the discomfort. In this mode the train ran more slowly, however. The train ran equally fast in the predictive and reactive modes when it tilted, but passenger comfort was significantly better when the train tilted just at the onset and end of the curves in the predictive mode.

The Mount Sinai team collaborated with scientists from Zurich University Hospital, Brooklyn College of CUNY, SBB, and Alston Schienenfahzeuge AG, a European transport company.

About The Mount Sinai Medical Center

The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine has more than 3,400 faculty in 32 departments and 16 institutes. It consistently ranks among the top 20 medical schools both in National Institutes of Health (NIH) funding and by U.S. News & World Report. The medical school also ranks third in NIH funding per faculty member. The school received the 2009 Spencer Foreman Award for Outstanding Community Service from the Association of American Medical Colleges.

The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation's oldest, largest and most-respected voluntary hospitals. In 2011, U.S. News & World Report ranked The Mount Sinai Hospital 16th on its elite honor roll of the nation's top hospitals based on reputation, patient safety, and other patient-care factors. Of the top 20 hospitals in the United States, Mount Sinai is one of only 12 who employs a best-in-class integrated business model that seamlessly combines its management, governance and information technology with a medical school. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 560,000 outpatient visits took place.

Jeanne Bernard | EurekAlert!
Further information:
http://www.mountsinai.org

Further reports about: GPS data Medical Wellness NIH Sinai Velocity centrifugal force motion sickness

More articles from Life Sciences:

nachricht Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory

nachricht How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>